Active, not recruitingPhase 1NCT05972629
A Phase 1/Phase 2 Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of a Single Intravenous Administration of SAR444836 in Adult Participants With Phenylketonuria
Studying Phenylketonuria
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Sanofi
- Principal Investigator
- Clinical Sciences & OperationsSanofi
- Intervention
- SAR444836(drug)
- Enrollment
- 32 enrolled
- Eligibility
- 18-65 years · All sexes
- Timeline
- 2023 – 2030
Study locations (11)
- University of California San Francisco- Site Number : 8400007, San Francisco, California, United States
- Children's Hospital IMD Clinic- Site Number : 8400015, Aurora, Colorado, United States
- University of Florida-Genetics- Site Number : 8400010, Gainesville, Florida, United States
- UHCMC- Site Number : 8400014, Cleveland, Ohio, United States
- UPMC Children's Hospital of Pittsburgh-4401 Penn Ave- Site Number : 8400018, Pittsburgh, Pennsylvania, United States
- Medical University of SC- Site Number : 8400004, Charleston, South Carolina, United States
- University of Texas- Site Number : 8400002, Houston, Texas, United States
- Investigational Site Number : 0320002, Ciudad Autonoma Buenos Aires, Buenos Aires, Argentina
- Hospital de Clinicas de Porto Alegre - HCPA- Site Number : 0760001, Porto Alegre, Rio Grande do Sul, Brazil
- Investigational Site Number : 3760001, Tel Litwinsky, Israel
- Investigational Site Number : 7920001, Ankara, Turkey (Türkiye)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05972629 on ClinicalTrials.govOther trials for Phenylketonuria
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT06971731A Study to Evaluate the Safety and Efficacy of JNT-517 in Participants With Phenylketonuria (PKU)Otsuka Pharmaceutical Development & Commercialization, Inc.
- ACTIVE NOT RECRUITINGPHASE1NCT07255599Evaluation of BH4 Responsiveness in Our PKU PatientsSohag University
- RECRUITINGNANCT06941532GMP Powdered Substitutes in PKU and TYRNutricia UK Ltd
- ENROLLING BY INVITATIONNANCT06940193A Self-test Home-use Blood Phenylalanine Monitoring System Under the Brand Name Egoo Phe System Has Been Developed for Measurement of Phenylalanine (Phe) in Individuals Diagnosed With Phenylketonuria (PKU): The Study Purpose is to Evaluate Accuracy and UsabilityEgoo Health Aps
- ACTIVE NOT RECRUITINGPHASE4NCT06901323Effect of L-carnitine Supplementation on Phenylalanine and Brain-derived Neurotrophic Factor Levels in Infants and Children With PhenylketonuriaMansoura University
- RECRUITINGNANCT06969209Brain Aging in PhenylketonuriaInsel Gruppe AG, University Hospital Bern
- RECRUITINGPHASE1NCT06332807AAV Gene Therapy Clinical Study in Adult Classic PKU (PHEdom)NGGT INC.
- RECRUITINGNANCT06560736Development of Novel Psychological Assessment Tools and Anxiety Intervention for PhenylketonuriaUniversity of Missouri-Columbia